AN ACT TO PROVIDE THAT THE STATE DEPARTMENT OF HEALTH SHALL APPOINT A RESEARCH 1 (R1) MISSISSIPPI UNIVERSITY TO CONDUCT A STUDY ON THE PREVENTION AND REDUCTION OF AMPUTATIONS RESULTING FROM DIABETES AND RELATED COMPLICATIONS; TO SPECIFY THE SUBJECTS TO BE EVALUATED BY THE STUDY; TO PROVIDE FOR THE MEMBERS OF THE STUDY COMMITTEE; TO REQUIRE THE STUDY COMMITTEE TO SUBMIT A REPORT ON THE RESULTS OF THE STUDY AND RECOMMENDATIONS TO CERTAIN LEGISLATIVE COMMITTEES BY DECEMBER 1, 2026; AND FOR RELATED PURPOSES.
Summary
HB1322 directs the Mississippi State Department of Health to conduct a study on preventing and reducing amputations caused by diabetes and related complications. The study must examine the prevalence of diabetes-related amputations in the state, the cost to the state of treating and caring for those cases, evidence-based prevention practices, and ways to expand access to limb-saving services such as multidisciplinary care teams, wound care, podiatry, and patient education. It also calls for consideration of public-private partnerships that could help lower amputation rates.
The bill requires the department’s executive director to appoint a workgroup of subject matter experts and stakeholders to assist with the study. By December 1, 2026, the department must submit a report with findings and recommendations to the chairs and members of the House Public Health and Human Services Committee and the Senate Public Health and Welfare Committee. The act takes effect upon passage and does not itself create a new regulatory program or mandate treatment coverage; instead, it establishes a fact-finding and policy-recommendation process.
Impact
HB1322 would not directly amend existing health coverage, licensing, or treatment statutes, but it would impose a new duty on the State Department of Health to study diabetes-related amputations and report policy recommendations to legislative committees. The practical effect is to create an official state review of the public health and fiscal burden of diabetic limb loss and to inform possible future legislation on screening, care coordination, wound care access, and prevention programs. The bill affects the Department of Health, legislative health committees, and stakeholders in diabetes care, podiatry, wound care, and hospital or clinic systems.
Sentiment
The available context suggests generally positive, noncontroversial support for the bill’s public health focus. The measure is framed as a study and report requirement rather than a spending or regulatory mandate, which typically makes it easier to support across stakeholders. No committee transcript or vote record is provided, so there is no evidence of organized opposition or divided sentiment in the materials available.
Contention
There is little explicit contention in the bill text or provided context. The main policy questions embedded in the study are whether the state should prioritize prevention programs, how much the state is spending on diabetes-related amputations, and what role public-private partnerships should play. If any disagreement emerges, it would likely center on the scope of the study, the use of state resources for the workgroup and report, and whether recommendations should lead to new mandates or funding commitments later on.